Unexpectedly, a remarkable result reported here is the discovery that an introduction of mutant BrafV600E into tanycytes is sufficient to drive tumor formation at the floor of the third ventricle, demonstrating that tanycytes have tumorigenic potential and are susceptible to Braf mutation. The gene discussed is BRAF; the disease is neoplasm.